| Overview |
| bsm-61325r-cy3-100ul |
| STIM1 Recombinant Antibody, Cy3 Conjugated |
| WB, IF |
| Human, Mouse, Rat |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Stromal interaction molecule 1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 6786 |
| Q13586 |
| Cytoplasm, Cell membrane |
| GOK; SIM; STIM 1; Stim1 stromal interaction molecule 1; STIM1L; Stromal interaction molecule 1. |
| STIM1 is a potential tumor suppressor; defects in STIM1 may cause rhabdomyosarcoma and rhabdoid tumors. STIM1 can either homodimerize or form heterodimers with STIM2. STIM2 possesses a high sequence identity to STIM1 and can function as an inhibitor of STIM1-mediated plasma membrane store-operated Ca2+ entry. However, further investigation is required to elucidate the true physiological function of STIM2. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz